Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32310553&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Ophthalmic Manifestations of Coronavirus (COVID-19) #MMPMID32310553
Hu K; Patel J; Swiston C; Patel BC
StatPearls-/-? 2025[Jan]; ? (?): ? PMID32310553show ga
Beginning in December 2019, COVID-19 developed into a global pandemic caused by the highly transmissible SARS-CoV-2. Numerous anecdotal and published reports initially indicated eye redness and irritation in patients with COVID-19, supporting conjunctivitis as an ocular manifestation of SARS-CoV-2 infection. Ongoing reports reveal associations between COVID-19 and uveitic, retinovascular, and neuro-ophthalmic disease. During the 2003 severe acute respiratory syndrome (SARS) outbreak, a study identified SARS-CoV in tear samples collected in Singapore from patients with SARS. The absence of eye protection emerged as a primary risk factor for SARS-CoV transmission from patients to healthcare workers in Toronto, raising concerns about the potential for respiratory illnesses to be transmitted through ocular secretions. Similar concerns have been expressed regarding SARS-CoV-2, particularly among eye care providers and frontline personnel responsible for assessing patients with the potential initial symptoms of COVID-19. Dr Li Wenliang, an opthalmologist, was among the first to express apprehensions about the coronavirus transmission in Chinese patients. Unfortunately, he succumbed to COVID-19, and it was suspected that he contracted the virus from an asymptomatic glaucoma patient in his clinic.
StatPearls-/-? 2025 ; ? (?): ?
